$BRZH
Breeze Holdings Acquisition Corp. Stock $brzh

$brzh Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024028925 Filed on April 01, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$506.7K	$2.070M
YoY Change		-28.88%	-10.89%
Operating Profit	-$537.4K		-$2.070M
YoY Change	77.17%		-10.89%
Interest Expense	$171.0K	$167.6K	$554.7K
YoY Change	12.36%		68128.91%
% of Operating Profit
Other Income/Expense, Net	$17.65M	$1.016M	-$460.8K
YoY Change	-1568.38%	-400.0%	-107.54%
Pretax Income	$17.11M	$676.4K	-$2.531M
YoY Change	-1236.75%	-164.36%	-166.77%
Income Tax	$6.264K	-$15.63K	$18.17K
% Of Pretax Income	0.04%	-2.31%
Net Earnings	$17.10M	$692.0K	-$2.549M
YoY Change	-1232.46%	-165.95%	-167.29%
Net Earnings / Revenue
Basic Earnings Per Share	$4.05		-$0.58
Diluted Earnings Per Share	$4.05	$0.16	-$0.58
COMMON SHARES
Basic Shares Outstanding	4.299M shares	4.299M shares	4.428M shares
Diluted Shares Outstanding	4.221M shares		4.428M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$4.230K	$4.230K
YoY Change		-70.06%	-70.06%
Cash & Equivalents	$39.97K	$4.228K
Short-Term Investments
Other Short-Term Assets		$261.9K	$261.9K
YoY Change		38.9%	38.9%
Inventory
Prepaid Expenses	$189.1K	$149.0K
Receivables
Other Receivables
Total Short-Term Assets	$311.3K	$266.1K	$266.2K
YoY Change	82.21%	31.3%	31.3%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$12.98M	$12.98M
YoY Change		-26.81%	-26.81%
Other Assets
YoY Change
Total Long-Term Assets	$10.38M	$12.98M	$12.98M
YoY Change	-19.15%	-26.81%	-26.81%
TOTAL ASSETS
Total Short-Term Assets	$311.3K	$266.1K	$266.2K
Total Long-Term Assets	$10.38M	$12.98M	$12.98M
Total Assets	$10.69M	$13.24M	$13.24M
YoY Change	-17.82%	-26.15%	-26.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$206.6K	$206.6K
YoY Change		206.13%	206.13%
Accrued Expenses		$56.27K	$56.27K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.894M	$8.077M	$8.077M
YoY Change	40.21%	45.53%	45.53%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$2.200M	$2.200M
YoY Change		85.71%	85.71%
Total Long-Term Liabilities		$2.200M	$2.200M
YoY Change		85.71%	85.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.894M	$8.077M	$8.077M
Total Long-Term Liabilities		$2.200M	$2.200M
Total Liabilities	$15.75M	$10.28M	$10.28M
YoY Change	67.09%	52.59%	52.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.34M	-$9.682M
YoY Change	69.54%	48.22%
Common Stock	$315.00	$315.00
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$15.34M	-$9.682M	$2.966M
YoY Change
Total Liabilities & Shareholders Equity	$10.69M	$13.24M	$13.24M
YoY Change	-17.82%	-26.15%	-26.15%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$17.10M	$692.0K	-$2.549M
YoY Change	-1232.46%	-165.95%	-167.29%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		-$688.4K	-$2.025M
YoY Change		-49.54%	-33.02%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$121.7K	$5.308M
YoY Change		-36.49%	-94.71%
Cash From Investing Activities		-$121.7K	$5.308M
YoY Change		-36.49%	-94.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$5.627M
YoY Change			-94.46%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		632.7K	-$3.293M
YoY Change		-59.7%	-96.62%
NET CHANGE
Cash From Operating Activities		-688.4K	-$2.025M
Cash From Investing Activities		-121.7K	$5.308M
Cash From Financing Activities		632.7K	-$3.293M
Net Change In Cash		-177.5K	-$9.901K
YoY Change		-1363.06%	-213.47%
FREE CASH FLOW
Cash From Operating Activities		-$688.4K	-$2.025M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3790313	usd
CY2022	brez	Non Cash Excise Taxes Payable NonCashExciseTaxesPayable		usd
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	brez	Business Combination Right Convertible Share Of Common Stock Conversion Ratio BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio	0.05	pure
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001817640
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000	shares
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000	shares
CY2023Q4	brez	Business Combination Right Convertible Share Of Common Stock Conversion Ratio BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio	0.05	pure
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Registrant Name EntityRegistrantName	BREEZE HOLDINGS ACQUISITION CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity File Number EntityFileNumber	001-39718
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1849315
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	955 W. John Carpenter Fwy.
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100-929
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Irving
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75039
CY2023	dei	City Area Code CityAreaCode	(619)
CY2023	dei	Local Phone Number LocalPhoneNumber	500-7747
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	46445203	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4299276	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash Cash	4228	usd
CY2022Q4	us-gaap	Cash Cash	14129	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	148953	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	160503	usd
CY2023Q4	brez	Prepayment Franchise Taxes Current PrepaymentFranchiseTaxesCurrent	57550	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	17730969	usd
CY2023Q4	us-gaap	Assets Assets	13243673	usd
CY2022Q4	us-gaap	Assets Assets	17933674	usd
CY2022Q4	brez	Prepayment Franchise Taxes Current PrepaymentFranchiseTaxesCurrent	10000	usd
CY2023Q4	brez	Prepayment Income Taxes Current PrepaymentIncomeTaxesCurrent	36742	usd
CY2022Q4	brez	Prepayment Income Taxes Current PrepaymentIncomeTaxesCurrent		usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	266145	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	202705	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	12977528	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5923750	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	206639	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	67500	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2089	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	56270	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent		usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5550530	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2200250	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1184750	usd
CY2023Q4	us-gaap	Liabilities Liabilities	10277665	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6735280	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196	shares
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	12647701	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	17730156	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	315	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	315	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9682008	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6532077	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9681693	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6531762	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13243673	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17933674	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2070143	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2323153	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2070143	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2323153	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	554701	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	813	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	188903	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1015500	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6113466	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-460799	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2530942	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18169	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2089	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2549111	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3788224	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4427788	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4427788	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9294000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8919146	usd
CY2022	brez	Common Stock Accretion To Redemption Value CommonStockAccretionToRedemptionValue	1400840	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3788224	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6531762	usd
CY2023	brez	Common Stock Accretion To Redemption Value CommonStockAccretionToRedemptionValue	544550	usd
CY2023	brez	Equity Adjustment Related To Excise Taxes Payable EquityAdjustmentRelatedToExciseTaxesPayable	56270	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2549111	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9681693	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-2549111	usd
CY2022	us-gaap	Profit Loss ProfitLoss	3788224	usd
CY2023	brez	Interest And Unrealized Gain Loss On Investments InterestAndUnrealizedGainLossOnInvestments	554701	usd
CY2022	brez	Interest And Unrealized Gain Loss On Investments InterestAndUnrealizedGainLossOnInvestments	189716	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1015500	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5923750	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-10951	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	54419	usd
CY2023	brez	Increase Decrease In Prepaid Franchise Taxes IncreaseDecreaseInPrepaidFranchiseTaxes	47550	usd
CY2022	brez	Increase Decrease In Prepaid Franchise Taxes IncreaseDecreaseInPrepaidFranchiseTaxes		usd
CY2023	brez	Increase Decrease In Prepaid Income Taxes IncreaseDecreaseInPrepaidIncomeTaxes	36742	usd
CY2022	brez	Increase Decrease In Prepaid Income Taxes IncreaseDecreaseInPrepaidIncomeTaxes		usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	95790	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	139139	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-530947	usd
CY2023	brez	Increase Decrease In Franchise Taxes Payable IncreaseDecreaseInFranchiseTaxesPayable		usd
CY2022	brez	Increase Decrease In Franchise Taxes Payable IncreaseDecreaseInFranchiseTaxesPayable	-210000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2089	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2089	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2024603	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3022729	usd
CY2023	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	528514	usd
CY2022	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	1400840	usd
CY2023	brez	Cash Withdrawn From Trust Account To Redeeming Shareholders CashWithdrawnFromTrustAccountToRedeemingShareholders	5627005	usd
CY2022	brez	Cash Withdrawn From Trust Account To Redeeming Shareholders CashWithdrawnFromTrustAccountToRedeemingShareholders	101545684	usd
CY2023	brez	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes	209650	usd
CY2022	brez	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes	231246	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5308141	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	100376090	usd
CY2023	brez	Proceeds From Short Term Working Capital Loan Related Party ProceedsFromShortTermWorkingCapitalLoanRelatedParty	1811900	usd
CY2023	brez	Proceeds From Promissory Note Related Party ProceedsFromPromissoryNoteRelatedParty	521666	usd
CY2022	brez	Proceeds From Promissory Note Related Party ProceedsFromPromissoryNoteRelatedParty	1400840	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5627005	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	101545684	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3293439	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-97344635	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9901	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8726	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14129	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5403	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4228	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14129	usd
CY2023	brez	Non Cash Excise Taxes Payable NonCashExciseTaxesPayable	56270	usd
CY2023	brez	Accretion Of Common Stocks Subject To Redemption Value AccretionOfCommonStocksSubjectToRedemptionValue	544550	usd
CY2022	brez	Accretion Of Common Stocks Subject To Redemption Value AccretionOfCommonStocksSubjectToRedemptionValue	1400840	usd
CY2020Q4	brez	Sale Of Private Placement Warrants SaleOfPrivatePlacementWarrants	5425000	shares
CY2020Q4	brez	Class Of Warrant Or Right Issue Price Of Warrants Or Rights Per Share ClassOfWarrantOrRightIssuePriceOfWarrantsOrRightsPerShare	1
CY2020Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	4099907	usd
CY2020Q4	brez	Underwriting Fees UnderwritingFees	2300000	usd
CY2020Q4	brez	Other Offering Costs OtherOfferingCosts	477557	usd
CY2023Q4	us-gaap	Cash Cash	4228	usd
CY2023Q4	brez	Aggregate Fair Market Value Of Acquisition Threshold As Percentage Of Assets Held In Trust Account AggregateFairMarketValueOfAcquisitionThresholdAsPercentageOfAssetsHeldInTrustAccount	0.80	pure
CY2023	brez	Minimum Voting Interest To Be Owned Or Acquired To Complete Business Combination MinimumVotingInterestToBeOwnedOrAcquiredToCompleteBusinessCombination	0.50	pure
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2023Q4	brez	Business Combination Minimum Threshold Limit Of Net Intangible Assets Required BusinessCombinationMinimumThresholdLimitOfNetIntangibleAssetsRequired	5000001	usd
CY2023	brez	Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination RestrictionOnPublicShareRedemptionInCaseOfStockholderApprovalOfBusinessCombination	0.10	pure
CY2023	brez	Business Combination Incomplete Percentage Of Stock Redemption BusinessCombinationIncompletePercentageOfStockRedemption	1	pure
CY2022Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.35
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	6732987	shares
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	69700628	usd
CY2022Q2	brez	Cash Withdrawn From Trust Account CashWithdrawnFromTrustAccount	109000	usd
CY2022Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.35
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	3076817	shares
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	31845056	usd
CY2022Q3	brez	Cash Withdrawn From Trust Account CashWithdrawnFromTrustAccount	122247	usd
CY2022Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.035
CY2022Q3	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	59157	usd
CY2022Q3	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	59157	usd
CY2023	brez	Business Combination Completion Date Of Acquisition BusinessCombinationCompletionDateOfAcquisition	2024-06-26
CY2023Q4	brez	Business Combination Incomplete Maximum Dissolution Expenses To Be Paid BusinessCombinationIncompleteMaximumDissolutionExpensesToBePaid	100000	usd
CY2023	brez	Assets Remaining Available For Distribution Per Share Maximum AssetsRemainingAvailableForDistributionPerShareMaximum	10.35
CY2023	brez	Assets Remaining Available For Distribution Per Share Maximum AssetsRemainingAvailableForDistributionPerShareMaximum	10.35
CY2022Q4	brez	Business Combination Expected To Close BusinessCombinationExpectedToClose	quarter of 2024
CY2023Q4	us-gaap	Cash Cash	4228	usd
CY2023Q4	brez	Working Capital Excluding Income And Excise Tax Payable WorkingCapitalExcludingIncomeAndExciseTaxPayable	-7849292	usd
CY2020Q4	brez	Proceeds From Sale Of Founder Shares ProceedsFromSaleOfFounderShares	25000	usd
CY2020Q4	brez	Proceeds From Unsecured And Non Interest Bearing Promissory Notes ProceedsFromUnsecuredAndNonInterestBearingPromissoryNotes	300000	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	509712	shares
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.56
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	5400000	usd
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	21208	shares
CY2023Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.77
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	231000000000	usd
CY2023Q1	brez	Percentage Of Excise Tax On Redemption Amount Paid PercentageOfExciseTaxOnRedemptionAmountPaid	0.01	pure
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	56270	usd
CY2023	brez	Percentage Of Excise Tax Liability Shares Redeemed PercentageOfExciseTaxLiabilitySharesRedeemed	0.01	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="border-left: none; border-right: none; line-height: 1.2;"> <div style="border-left: none; border-right: none;"> <div style="border-right: none; border-left: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none; line-height: 1.2;"> <div style="border-left: none; border-right: none;"> <div style="border-right: none; border-left: none;"> <div style="border-left: none; border-right: none;"> <p class="highlightCont" style="margin: 0px; text-indent: 0px; font-size: 1pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal;"><span style="font-size: 10pt; font-weight: bold; line-height: inherit;">Use of estimates</span></p> </div> </div> </div> </div> <div style="border-left: none; border-right: none; line-height: 1.2;"> <div style="border-left: none; border-right: none;"> <p class="highlightCont" style="margin-bottom: 0pt; margin-top: 10pt; text-indent: 0%; font-size: 10pt; font-family: Times New Roman; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal;">The preparation of the consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> </div> </div> </div> </div> </div> </div> </div> <div style="border-left: none; border-right: none; line-height: 1.2;"> <div style="border-left: none; border-right: none;"> <p class="highlightCont " style="margin-bottom: 0pt; margin-top: 10pt; text-indent: 0%; font-size: 10pt; font-family: Times New Roman; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to <span>one</span> or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> </div> </div>
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.35
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	3076817	shares
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196	shares
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.56
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	509712	shares
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2023Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.77
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	21208	shares
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2549111	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3788224	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4427788	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4427788	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9294000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9294000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-bottom: 0pt; margin-top: 0pt; text-indent: 0%; font-family: Times New Roman; font-size: 10pt;"><span style="font-size: 10pt; font-weight: bold; line-height: inherit;">Concentration of credit risk</span></p> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <p style="margin-bottom: 0pt; margin-top: 10pt; text-indent: 0%; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal; line-height: 1.2;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporate coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p> </div> </div>
CY2023	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	250000	usd
CY2023Q4	brez	Related Party Transaction Expenses Paid RelatedPartyTransactionExpensesPaid	178572	usd
CY2023Q4	brez	Related Party Transaction Due To Related Party RelatedPartyTransactionDueToRelatedParty	7814506	usd
CY2023Q4	brez	Deposits Held In Trust Account DepositsHeldInTrustAccount	40575	usd
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.035
CY2023	brez	Percentage Of Advisor Cash Fee On Gross Proceeds Of Initial Public Offering PercentageOfAdvisorCashFeeOnGrossProceedsOfInitialPublicOffering	0.0275	pure
CY2023	brez	Cash Fee For Advisory Services Upon Consummation Of Business Combination CashFeeForAdvisoryServicesUponConsummationOfBusinessCombination	3162500	usd
CY2022Q4	brez	Transaction Success Fee Payable Upon Merger Proxy Business Combination Rate Agreement TransactionSuccessFeePayableUponMergerProxyBusinessCombinationRateAgreement	50000	usd
CY2022Q1	brez	Service Fee Payable Upon Proxy Solicitation Services Agreement ServiceFeePayableUponProxySolicitationServicesAgreement	25000	usd
CY2023Q4	brez	Number Of Fractional Shares Issued Upon Exercise Of Public Warrant NumberOfFractionalSharesIssuedUponExerciseOfPublicWarrant	0	shares
CY2023	brez	Warrants Exercisable Period After Completion Of Business Combination WarrantsExercisablePeriodAfterCompletionOfBusinessCombination	P30D
CY2023	brez	Warrants Exercisable Period From Closing Of Initial Public Offering WarrantsExercisablePeriodFromClosingOfInitialPublicOffering	P12M
CY2023	brez	Warrant Expiration Period After Completion Of Business Combination Or Earlier Upon Redemption Or Liquidation WarrantExpirationPeriodAfterCompletionOfBusinessCombinationOrEarlierUponRedemptionOrLiquidation	P5Y
CY2023Q4	brez	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	0	shares
CY2023Q4	brez	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.01
CY2023	brez	Minimum Period Of Prior Written Notice Of Redemption Of Warrants MinimumPeriodOfPriorWrittenNoticeOfRedemptionOfWarrants	P30D
CY2023Q4	brez	Minimum Price Per Share Required For Redemption Of Warrants MinimumPricePerShareRequiredForRedemptionOfWarrants	18
CY2023	brez	Warrants Redemption Covenant Threshold Trading Days WarrantsRedemptionCovenantThresholdTradingDays	P20D
CY2023	brez	Warrants Redemption Covenant Threshold Consecutive Trading Days WarrantsRedemptionCovenantThresholdConsecutiveTradingDays	P30D
CY2023Q4	brez	Maximum Effective Issue Price To Closing Of Business Combination MaximumEffectiveIssuePriceToClosingOfBusinessCombination	9.2
CY2023Q4	brez	Minimum Percentage Of Equity Proceeds From Issuances MinimumPercentageOfEquityProceedsFromIssuances	0.60	pure
CY2023	brez	Number Of Trading Days Prior On Consummates Business Combination NumberOfTradingDaysPriorOnConsummatesBusinessCombination	P20D
CY2023Q4	brez	Maximum Effective Issue Price To Closing Of Business Combination MaximumEffectiveIssuePriceToClosingOfBusinessCombination	9.2
CY2023Q4	brez	Percentage Of Exercise Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price PercentageOfExercisePriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice	1.15	pure
CY2023Q4	brez	Minimum Price Per Share Required For Redemption Of Warrants MinimumPricePerShareRequiredForRedemptionOfWarrants	18
CY2023	brez	Percentage Of Redemption Triggered Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price PercentageOfRedemptionTriggeredPriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice	1.80	pure
CY2023	brez	Warrants Will Not Be Transferable Assignable Or Saleable Number Of Period After Completion Of Business Combination WarrantsWillNotBeTransferableAssignableOrSaleableNumberOfPeriodAfterCompletionOfBusinessCombination	P30D
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5425000	shares
CY2023Q4	brez	Class Of Warrant Or Right Issue Price Of Warrants Or Rights Per Share ClassOfWarrantOrRightIssuePriceOfWarrantsOrRightsPerShare	1
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5425000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1015500	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5923750	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of common stock are entitled to one vote for each share.
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196	shares
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	71824	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	23712	usd
CY2023Q4	brez	Deferred Tax Assets Capitalized Start Up Costs DeferredTaxAssetsCapitalizedStartUpCosts	777461	usd
CY2022Q4	brez	Deferred Tax Assets Capitalized Start Up Costs DeferredTaxAssetsCapitalizedStartUpCosts	598616	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	849285	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	622328	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0751	pure
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	849285	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	622328	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	18169	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2089	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-226958	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-284667	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	226958	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	284667	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18169	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2089	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	342018	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	112925	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	849285	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	622328	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	brez	Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfWarrantLiabilities	-0.0843	pure
CY2022	brez	Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Warrant Liabilities EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfWarrantLiabilities	-0.3282	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.0419	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.0191	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.0826	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0246	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0897	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0025	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments		pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0072	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0006	pure
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1184750	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-1015500	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2200250	usd

Files In Submission

Name	View Source	Status
0001213900-24-028925-index-headers.html	Edgar Link	pending
0001213900-24-028925-index.html	Edgar Link	pending
0001213900-24-028925.txt	Edgar Link	pending
0001213900-24-028925-xbrl.zip	Edgar Link	pending
brez-20231231.htm	Edgar Link	pending
brez-20231231.xsd	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex321_2.htm	Edgar Link	pending
ex971_3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
brez-20231231_cal.xml	Edgar Link	unprocessable
brez-20231231_def.xml	Edgar Link	unprocessable
brez-20231231_lab.xml	Edgar Link	unprocessable
brez-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
brez-20231231_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BRZH
Breeze Holdings Acquisition Corp. Stock $brzh

2024 Q2 Form 10-K Financial Statement

#000121390024028925 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRZH Breeze Holdings Acquisition Corp. Stock $brzh

2024 Q2 Form 10-K Financial Statement

#000121390024028925 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRZH
Breeze Holdings Acquisition Corp. Stock $brzh